Following children and young people who receive orthopaedic implants for bone problems
Follows children with broken bones or limb deformities who receive bone implant devices.
Plain-language title generated from the registry record
Registry title: Pediatric Orthopaedic Implant Safety & Efficacy
Key facts
- Where
- Vancouver, CanadaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 0 and 25 years old?
Source: NCT05361980, who can take part
Where in Canada
- BC Children ' s HospitalVancouver, CanadaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of British Columbia
- Trial code
- NCT05361980
- Record updated
- 9 November 2026
- Original description
Implant devices are important tools - their use is essential across a number of orthopaedic indications, including hip conditions, trauma and limb deformity.Read full original descriptionShow less
Global Pediatric Orthopaedic Implant Safety & Efficacy Clinical Follow-up Program
Implant devices are important tools - their use is essential across a number of orthopaedic indications, including hip conditions, trauma and limb deformity.
Given the vital role fixation devices play in maintaining alignment, promoting healthy bone healing and preventing joint degeneration, it is essential to understand the expected lifetime outcomes of these implants, and evaluate their safety and efficacy.
Prospective implant efficacy and safety registries are needed to support this endeavour, especially considering new regulatory requirements from the European Union Medical Devices Regulation (EU MDR) in relation to post-market clinical follow-up (PMCF).
Inclusion: Patients indicated for the device-specific indication, per physician discretion and as indicated in the device IFU. Off-label use is strongly discouraged; however, any and all on- and off-label indications for use of the products in this program will be collected and stratified accordingly; Patients must be able to adhere to the required length of follow-up for the endpoints of each individual product; Informed consent/assent is required.
Exclusion: Patients with a demonstrated sensitivity to metals; Patients with an inability to follow a post-operative regimen.